Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing for Hereditary Nonpolyposis Colon Cancer
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
RATIONALE: Identifying family and individual characteristics may help plan education and counseling for patients who are considering genetic testing.
PURPOSE: This clinical trial is studying education and counseling to see what effect they have in patients who are undergoing genetic testing for hereditary nonpolyposis colon cancer (recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues).
| Condition | Intervention |
|---|---|
|
Colorectal Cancer |
Genetic: loss of heterozygosity analysis Genetic: microsatellite instability analysis Genetic: mutation analysis Other: counseling intervention |
| Study Type: | Interventional |
| Official Title: | Outcomes in Education and Counseling for HNPCC Testing |
| Estimated Enrollment: | 900 |
| Study Start Date: | February 2000 |
OBJECTIVES:
- Identify family characteristics, personality traits, and religious and spiritual beliefs that significantly affect individual decisions regarding mutation testing for hereditary nonpolyposis colon cancer (HNPCC) (recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues).
- Determine the impact of negative vs positive mutation test results on family relationships and psychological status.
- Assess expectations regarding testing and how they influence perceptions of risks and responses to risk notification.
- Determine the impact of risk notification on the frequency of screening/prevention activities.
- Formulate a standard diagnostic algorithm for determining microsatellite instability based on the analysis of tumors with this extensive array of markers and correlate specific replication error phenotypes with germline genotype.
OUTLINE: Participants complete a baseline assessment of knowledge, risk perception, and personality traits followed by a structured pretest education session. Participants are then offered the choice of whether or not to undergo genetic testing for mutations in hereditary nonpolyposis colon cancer (HNPCC) genes. Participants who choose to undergo genetic testing provide a blood sample for this purpose. Participants who undergo genetic testing receive results and counseling (recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues).
Available surveillance options are discussed for all participants. Psychological and behavioral outcomes are reassessed at 6 and 12 months for both those choosing and not choosing genetic testing.
Tumors (when available) are analyzed for mismatched repair deficiency on the basis of microsatellite instability.
PROJECTED ACCRUAL: A total of 900 participants will be accrued for this study, with a specific target of 200 individuals who have not experienced cancer within families identified with hereditary nonpolyposis colon cancer (HNPCC) mutations (recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues).
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Meets one of the following criteria:
Family history consistent with hereditary nonpolyposis colon cancer (HNPCC)*
- At least 3 relatives with histologically proven colorectal cancer or HNPCC-associated cancer and 1 is a first-degree relative of the other 2
- At least 2 successive generations affected
- Colorectal cancer (or HNPCC-associated cancer) diagnosed under age 50 in 1 of the relatives
- Diagnosis of colorectal cancer under age 41
- HNPCC-associated cancer/polyps* under age 41 with a microsatellite instability (MSI) phenotype
- Multiple primary HNPCC-associated cancers* regardless of family history
Colorectal or other HNPCC-associated tumor/polyp* demonstrating a positive MSI phenotype and at least 1 second-degree (or closer) and 1 third-degree (or closer) relative with a HNPCC-associated cancer
1 affected family member must have one of the following:
- Right-sided colon cancer
- Multiple primary HNPCC-associated cancers
- Diagnosis of cancer prior to age 51 NOTE: *Recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues
PATIENT CHARACTERISTICS:
Age:
- 18 and over
Performance status:
- Not specified
Life expectancy:
- Not specified
Hematopoietic:
- Not specified
Hepatic:
- Not specified
Renal:
- Not specified
PRIOR CONCURRENT THERAPY:
Biologic therapy:
- Not specified
Chemotherapy:
- Not specified
Endocrine:
- Not specified
Radiotherapy:
- Not specified
Surgery:
- Not specified
Contacts and Locations| United States, Maryland | |
| National Human Genome Research Institute | Recruiting |
| Bethesda, Maryland, United States, 20892-4470 | |
| Contact: Clinical Trials Office - National Human Genome Research Instit 301-402-8255 | |
| Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office | Recruiting |
| Bethesda, Maryland, United States, 20892-1182 | |
| Contact: Clinical Trials Office - Warren Grant Magnusen Clinical Center 888-NCI-1937 | |
| Study Chair: | Donald W. Hadley, MS, CGC | National Human Genome Research Institute (NHGRI) |
More Information
Additional Information:
Publications:
| ClinicalTrials.gov Identifier: | NCT00004210 History of Changes |
| Obsolete Identifiers: | NCT00001470 |
| Other Study ID Numbers: | CDR0000067459, NCI-95-HG-0165, NCI-NMOB-9501, NHGRI-95-HG-0165 |
| Study First Received: | January 21, 2000 |
| Last Updated: | July 28, 2011 |
| Health Authority: | Unspecified |
Keywords provided by National Cancer Institute (NCI):
|
colon cancer rectal cancer |
Additional relevant MeSH terms:
|
Colonic Neoplasms Colorectal Neoplasms Colorectal Neoplasms, Hereditary Nonpolyposis Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site Neoplasms Digestive System Diseases |
Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases Neoplastic Syndromes, Hereditary Genetic Diseases, Inborn DNA Repair-Deficiency Disorders Metabolic Diseases |
ClinicalTrials.gov processed this record on May 22, 2013